DRI raises $700m for healthcare royalties

The Toronto-based investment firm beat its initial target of $500m for its second drug royalties fund.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this